Improvement in Hereditary Hemorrhagic Telangiectasia After Treatment with the Phosphoinositide 3-kinase Inhibitor BKM120
Overview
Affiliations
Hereditary hemorrhagic telangiectasia: from signaling insights to therapeutic advances.
Al Tabosh T, Al Tarrass M, Tourvieilhe L, Guilhem A, Dupuis-Girod S, Bailly S J Clin Invest. 2024; 134(4).
PMID: 38357927 PMC: 10866657. DOI: 10.1172/JCI176379.
Riera-Mestre A, Cerda P, Guzman Y, Iriarte A, Torroella A, Mora-Lujan J J Clin Med. 2022; 11(19).
PMID: 36233492 PMC: 9573297. DOI: 10.3390/jcm11195624.
Pathogenesis and therapy of arteriovenous malformations: A case report and narrative review.
Tessier S, Lipton B, Ido F, Longo S, Nanda S Int J Crit Illn Inj Sci. 2021; 11(3):167-176.
PMID: 34760664 PMC: 8547675. DOI: 10.4103/IJCIIS.IJCIIS_127_20.
Albinana V, Cuesta A, de Rojas-P I, Gallardo-Vara E, Recio-Poveda L, Bernabeu C J Clin Med. 2020; 9(6).
PMID: 32517280 PMC: 7356836. DOI: 10.3390/jcm9061766.
Future treatments for hereditary hemorrhagic telangiectasia.
Robert F, Desroches-Castan A, Bailly S, Dupuis-Girod S, Feige J Orphanet J Rare Dis. 2020; 15(1):4.
PMID: 31910860 PMC: 6945546. DOI: 10.1186/s13023-019-1281-4.